Skip to main content
Premium Trial:

Request an Annual Quote

Solexa Appoints John West as New CEO

NEW YORK, Aug. 27 (GenomeWeb News) - Solexa announced to day that it has appointed John West as its new CEO. Before joining Solexa, West was the vice president of DNA platforms at Applied Biosystems.


West replaces Nick McCooke, who led Solexa through its early period in developing single molecule arrays.


"On joining Solexa, I have been impressed with how far it has progressed toward practical implementation," said West. "While other companies propose stretching the microtiter plate concept to the limit with expensive microfluidic designs, Solexa has moved directly to the molecular level. This promises thousand fold higher density thanthe finest microfluidic chambers, with none of the complexity."


Aside from working at Applied Biosystems, West has also held senior positions as president of Princeton Instruments, president and founder of BioAutomation and marketing director for microfluidics at Microcosm Technologies. West has been working in the biotechnology industry for 22 years.


West's appointment came after Lynx Therapeutics announced that the company may be merging with Solexa for $2.5 million in loans (see GenomeWeb Aug. 13 story).

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.